181 related articles for article (PubMed ID: 3289643)
1. [Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogenic grafts of the bone marrow. A retrospective study of 54 patients with malignant hematologic diseases].
Baume D; Cosset JM; Pico JL; Girinski T; Le Bail N; Nabholtz JM; Benhamou E; Dutreix J; Hayat M
Bull Cancer; 1988; 75(4):361-72. PubMed ID: 3289643
[TBL] [Abstract][Full Text] [Related]
2. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
3. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institut Gustave-Roussy.
Cosset JM; Baume D; Pico JL; Shank B; Girinski T; Benhamou E; Briot E; Malaise E; Hayat M; Dutreix J
Radiother Oncol; 1989 Jun; 15(2):151-60. PubMed ID: 2669036
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
5. Total body irradiation in bone marrow transplantation: fractionated vs single dose. Acute toxicity and preliminary results.
Valls A; Grañena A; Carreras E; Ferrer E; Algara M
Bull Cancer; 1989; 76(8):797-804. PubMed ID: 2695178
[TBL] [Abstract][Full Text] [Related]
6. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation.
Aristei C; Alessandro M; Santucci A; Aversa F; Tabillo A; Carotti A; Latini RA; Cagini C; Latini P
Bone Marrow Transplant; 2002 Mar; 29(6):503-7. PubMed ID: 11960270
[TBL] [Abstract][Full Text] [Related]
7. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
[TBL] [Abstract][Full Text] [Related]
8. [Whole body irradiation in conditioning for bone marrow transplantation. Experiences with 35 cases of leukemia].
Prosperini G; Santeusanio E; Di Bartolomeo P; Iacone A; Muzii G
Radiol Med; 1985 Apr; 71(4):243-7. PubMed ID: 3901148
[TBL] [Abstract][Full Text] [Related]
9. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
Sutton L; Kuentz M; Cordonnier C; Blaise D; Devergie A; Guyotat D; Leblond V; Flesch M; Bordigoni P; Attal M
Bone Marrow Transplant; 1993 Dec; 12(6):583-9. PubMed ID: 8136742
[TBL] [Abstract][Full Text] [Related]
11. [Fractionated and hyperfractionated total body irradiation in the conditioning of allogenic bone marrow transplant in acute lymphatic leukemia. Results].
Corvò R; Frassoni F; Franzone P; Barra S; Guenzi M; Orsatti M; Fiorino R; Scarpati D; Vitale V
Radiol Med; 1989 Oct; 78(4):367-72. PubMed ID: 2687967
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
13. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
Belkacémi Y; Labopin M; Hennequin C; Hoffstetter S; Mungai R; Wygoda M; Lundell M; Finke J; Aktinson C; Lorchel F; Durdux C; Basara N
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):544-51. PubMed ID: 17141976
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
15. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
16. Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
Corvò R; Lamparelli T; Bruno B; Barra S; Van Lint MT; Vitale V; Bacigalupo A
Bone Marrow Transplant; 2002 Dec; 30(11):717-23. PubMed ID: 12439693
[TBL] [Abstract][Full Text] [Related]
17. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
[TBL] [Abstract][Full Text] [Related]
18. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
19. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.
Girinsky T; Benhamou E; Bourhis JH; Dhermain F; Guillot-Valls D; Ganansia V; Luboinski M; Perez A; Cosset JM; Socie G; Baume D; Bouaouina N; Briot E; Beaudre A; Bridier A; Pico JL
J Clin Oncol; 2000 Mar; 18(5):981-6. PubMed ID: 10694547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
